Table 1.
Correlation between COL9A3/COL6A5 protein expression and clinicopathologic characteristics of GC.
| Characteristics | Total (n = 94) | COL9A3 | P value | COL6A5 | P value | ||
|---|---|---|---|---|---|---|---|
| Low | High | Low | High | ||||
| Age (years) | 0.913 | 0.613 | |||||
| <55 | 25 | 9 | 16 | 8 | 17 | ||
| ≥55 | 69 | 24 | 45 | 26 | 43 | ||
| Gender | 0.238 | 0.359 | |||||
| Male | 39 | 11 | 28 | 12 | 27 | ||
| Female | 55 | 22 | 33 | 22 | 33 | ||
| Differentiation | 0.006 | 0.002 | |||||
| Well | 28 | 16 | 12 | 17 | 11 | ||
| Moderate | 33 | 11 | 22 | 11 | 22 | ||
| Poor | 33 | 6 | 27 | 6 | 27 | ||
| Lymph node metastasis | <0.001 | <0.001 | |||||
| Positive | 71 | 16 | 55 | 17 | 54 | ||
| Negative | 23 | 17 | 6 | 17 | 6 | ||
| Tumour size (cm3) | <0.001 | <0.001 | |||||
| <10 | 23 | 19 | 4 | 19 | 4 | ||
| ≥10 | 71 | 15 | 56 | 15 | 56 | ||
| AJCC T stage | <0.001 | <0.001 | |||||
| T1, T2 | 14 | 12 | 2 | 12 | 2 | ||
| T3, T4 | 80 | 21 | 59 | 22 | 58 | ||
| Clinical TNM stage | <0.001 | <0.001 | |||||
| I, II | 38 | 26 | 12 | 26 | 12 | ||
| III, IV | 56 | 7 | 49 | 8 | 48 | ||